CRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money?
This year, the biotech stock has underperformed both the Nasdaq Biotechnology Index and the S&P 500.
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
| المطلع | المنصب | التاريخ | النوع | القيمة |
|---|---|---|---|---|
| Muniz Quintanilla Daniel | Director | Feb 06 '26 | Buy | 200882,0 |
| Whittaker Dawn Patricia | Director | Feb 04 '26 | Buy | 37440,0 |
| Dorward-King Elaine J | Director | Jan 27 '26 | Option Exercise | 350592,0 |
| Dorward-King Elaine J | Director | Jan 27 '26 | Sale | 115,0 |
المصدر: FinViz — قد تكون البيانات متأخرة
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر NG والمشاعر والاتجاه
This year, the biotech stock has underperformed both the Nasdaq Biotechnology Index and the S&P 500.
Shares of Jensen Huang’s company have struggled to make headway since its previous results day.
Hang Seng Indexes Co. is adding Hua Hong Grace Semiconductor Ltd. and Weichai Power Co. to Hong Kong’s equity benchmark, …
(Click here or type SQUA <GO> to listen to Bloomberg’s new EMEA Equities Squawk)
An ABC on ABCPs
Both of these entertainment giants have lost money for their shareholders in 2026.
تحليل متعدد المزودين بالذكاء الاصطناعي